Icahn School of Medicine at Mount Sinai Information Session
Join us to learn about the Icahn School of Medicine at Mount Sinai.
Categories |
|
---|---|
When |
Oct 21, 2020 from 04:00 pm to 05:00 pm |
Speaker | Dr. Valarie Parkas, Talia Swartz, M.D., Ph.D., Carrie Ernst |
Speaker Information | Dr. Valarie Parkas, Senior Associate Dean of Admissions and Recruitment; Talia Swartz, Assistant Professor in the Department of Medicine, Division of Infectious Diseases; Carrie Ernst, Assistant Professor in the Department of Psychiatry |
Where | Zoom Virtual Meeting |
Add event to calendar |
vCal iCal |
Your speakers for the event include:
Dr. Valarie Parkas, Senior Associate Dean of Admissions and Recruitment
Talia Swartz, Assistant Professor in the Department of Medicine, Division of Infectious Diseases
Carrie Ernst, Assistant Professor in the Department of Psychiatry
Dr. Parkas received both her undergraduate and medical degrees from Brown University and completed her residency training in internal medicine at New York Hospital-Cornell University Medical School and her fellowship in Infectious Diseases at Memorial Sloan Kettering. She came to the Icahn School of Medicine at Mount Sinai as an attending in the Department of Medicine, Division of Infectious Diseases in 1997. Dr. Parkas has been involved in both clinical care and medical education from the start of her career. Clinically, Dr. Parkas works at the HIV outpatient practice and takes care of HIV-infected inpatients as well.
Talia Swartz, MD, Ph.D., is an Assistant Professor in the Department of Medicine, Division of Infectious Diseases. She is board-certified in Internal Medicine and Infectious Disease. Her clinical training is in Infectious Diseases with a specific interest in HIV and her basic science interest is in the biology that underlies chronic HIV infection. HIV is an incurable disease and while antiretroviral therapy is effective at suppressive viremia, long-term sequelae of inflammation account for premature aging, higher rates of cardiovascular disease, and neoplasms. Dr. Swartz’s research seeks to identify novel mechanisms of HIV-associated inflammation through membrane signaling.